XML 12 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Current Assets    
Cash and cash equivalents $ 7,129 $ 17,116
Prepaid expenses and other current assets 535 827
Total Current Assets 7,664 17,943
Property and equipment, net 731 872
Deposits and other assets 23 23
Total Assets 8,418 18,838
Current Liabilities:    
Accounts payable 1,217 2,020
Accrued expenses 1,000 1,526
Warrant liabilities 645 4,083
Accrued employee benefits 1,362 2,074
Deferred rent 95 90
Total Current Liabilities 4,319 9,793
Long term deferred rent 353 402
Total Liabilities 4,672 10,195
Series A convertible preferred stock, $0.001 par value; 10,000,000 shares authorized,120,000 issued and outstanding 12,173 12,053
Stockholders' Deficit:    
Common stock,  $0.001 par value; 350,000,000 shares authorized,130,380,517 issued and 130,299,305 outstanding and 117,254,196 issued and 117,172,714 outstanding 130 129
Additional paid-in capital 194,186 192,545
Accumulated deficit (200,803) (194,170)
Total Synthetic Biologics, Inc. and Subsidiaries Deficit (6,487) (1,496)
Non-controlling interest (1,940) (1,914)
Total Stockholders' Deficit (8,427) (3,410)
Total Liabilities and Stockholders' Deficit $ 8,418 $ 18,838